Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) Interest Expenses (2019 - 2025)

Quantum Biopharma's Interest Expenses history spans 7 years, with the latest figure at -$72637.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 3973.97% to -$72637.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $158063.0, a 378.73% increase, with the full-year FY2025 number at $158063.0, up 378.73% from a year prior.
  • Interest Expenses hit -$72637.0 in Q4 2025 for Quantum Biopharma, down from $91570.0 in the prior quarter.
  • Over the last five years, Interest Expenses for QNTM hit a ceiling of $116962.0 in Q2 2025 and a floor of -$72637.0 in Q4 2025.
  • Historically, Interest Expenses has averaged $16379.0 across 5 years, with a median of $18917.0 in 2021.
  • Biggest five-year swings in Interest Expenses: skyrocketed 1761.17% in 2024 and later crashed 3973.97% in 2025.
  • Tracing QNTM's Interest Expenses over 5 years: stood at $18917.0 in 2021, then tumbled by 149.59% to -$9381.0 in 2022, then tumbled by 122.81% to -$20902.0 in 2023, then surged by 108.97% to $1875.0 in 2024, then crashed by 3973.97% to -$72637.0 in 2025.
  • Business Quant data shows Interest Expenses for QNTM at -$72637.0 in Q4 2025, $91570.0 in Q3 2025, and $116962.0 in Q2 2025.